New Complaint Filed in N.D.Tex. Challenges Mifepristone Regulation
Abstract
The States of Missouri, Kansas, and Idaho have sued the FDA challenging the regulatory framework for Mifepristone. The suit is filed in the United States District Court for the Northern District of Texas Amarillo Division.
Source Publication
Gender and Law Blog
Recommended Citation
Jamie Abrams,
New Complaint Filed in N.D.Tex. Challenges Mifepristone Regulation,
Gender and Law Blog
(2024).
Available at:
https://digitalcommons.wcl.american.edu/pub_disc_media/593
COinS